Labs & Testing8 min read·Published September 21, 2026·Updated October 28, 2026

Mitochondrial Antibody Test: Positive or Negative

What an AMA or AMA-M2 blood test can mean for liver health—and what it does not measure.

Mitochondrial Antibody Test: What a Positive or Negative Result Can Mean

A mitochondrial antibody test is a blood test that looks for anti-mitochondrial antibodies, often called AMA. Clinicians commonly order it when evaluating possible autoimmune liver disease, especially primary biliary cholangitis (PBC). A positive or negative result needs to be read alongside liver enzymes, symptoms, medical history, and sometimes imaging or specialist care 1 2.

Not sure where to start? Take the 3-min clinical quiz.

See if you qualify →

What is a mitochondrial antibody test?

A mitochondrial antibody test checks blood for anti-mitochondrial antibodies. These are autoantibodies: immune proteins that react with parts of the body’s own cells. The test is primarily used as part of an autoimmune liver-disease evaluation, not as a test of how well mitochondria make energy 1 2.

Other names: AMA, anti-mitochondrial antibody, mitochondrial M2 antibody

The same test may be labeled AMA, anti-mitochondrial antibody, mitochondrial antibody, mitochondrial M2 antibody, or AMA-M2. AMA is the broader term. AMA-M2 identifies antibodies against a target that is closely associated with PBC 3.

What does the blood test measure?

The test measures antibodies in the serum portion of blood. Laboratories can use different methods, including indirect immunofluorescence assay (IFA) and enzyme-linked immunosorbent assay (ELISA). Because methods and reporting units differ, the reference range printed on your own report matters 4.

How is this different from mitochondrial DNA testing?

AMA testing looks for an immune marker connected with liver disease. Mitochondrial genetic testing, by contrast, looks for changes in mitochondrial DNA or nuclear genes that may affect mitochondrial biology 6. Our guide to genomic DNA versus mitochondrial DNA explains why those are different kinds of tests.

Why would a clinician order an anti-mitochondrial antibody test?

A clinician may order an anti-mitochondrial antibody test when liver blood tests suggest cholestasis, meaning bile may not be flowing normally. An elevated alkaline phosphatase level is a common reason to investigate this pattern further 1 3.

  • Abnormal alkaline phosphatase, bilirubin, gamma-glutamyl transferase, or other liver-panel results 2.
  • Symptoms that can occur with cholestatic liver disease, including fatigue, itching, jaundice, dark urine, or dry eyes and mouth 2.
  • An evaluation for autoimmune liver disease, including possible PBC or autoimmune hepatitis overlap 3.
  • Follow-up after a previous positive, borderline, or unclear antibody result.

Some people with PBC have no clear symptoms when it is first found. In that situation, an abnormal liver panel may be the first reason for further testing 2.

What diseases are linked to anti-mitochondrial antibodies?

Anti-mitochondrial antibodies are most strongly associated with primary biliary cholangitis. In PBC, the immune system is involved in injury to small bile ducts in the liver. Ongoing bile-duct injury can lead to cholestasis and, over time, liver scarring 1 3.

PBC was previously called primary biliary cirrhosis. The newer name is preferred because it can be recognized before cirrhosis develops. A positive AMA is one important piece of the diagnosis when the liver-test pattern also fits 3.

AMA can occasionally appear in people who do not have classic PBC. Depending on the liver-test pattern and personal history, clinicians may also consider medication-related liver injury, viral hepatitis, blockage of the bile ducts, autoimmune hepatitis, or another cause of abnormal liver tests 3 5.

What does a positive mitochondrial antibody result mean?

A positive mitochondrial antibody result means the laboratory detected AMA above its reporting cutoff. It can strongly support PBC when there is a cholestatic pattern of liver tests—particularly a persistently elevated alkaline phosphatase—but it is not a diagnosis on its own 1 3.

Does a high AMA level mean more severe disease?

Not necessarily. Some reports use a titer, while others give a numerical value or a positive-negative result. Antibody level alone does not establish disease severity, stage, or prognosis. Clinicians use liver enzymes, bilirubin, albumin, platelet count, symptoms, imaging, and other findings to understand the full picture 3 4.

When might AMA-M2 be used?

AMA-M2 may be included as part of a more specific antibody evaluation for suspected PBC, particularly when an initial result needs clarification. It is still interpreted with liver tests and clinical findings—not in isolation 3. For more detail on the lab name, see our guide to mitochondrial M2 antibody IgG.

What does a negative mitochondrial antibody result mean?

A negative AMA result means the lab did not detect anti-mitochondrial antibodies above that lab’s cutoff. It can make PBC less likely, but it does not rule out every liver disease, autoimmune condition, or every case of PBC 3.

A minority of people with PBC are AMA-negative. If liver tests still show cholestasis, a clinician may consider other PBC-specific antibodies, imaging, or a liver biopsy in selected situations 3 5.

A negative screen does not explain persistent itching, jaundice, or abnormal liver enzymes. Those findings still deserve follow-up with the ordering clinician.

How accurate is a mitochondrial antibody test?

The accuracy of an AMA test depends on the condition being evaluated, the laboratory method, and how likely PBC was before testing. AMA is a strong diagnostic marker for PBC, but guidelines use it with cholestatic liver tests and clinical context rather than as a stand-alone diagnosis 3 5.

A false-positive result means an antibody is detected without PBC being the explanation. A false-negative result means the antibody is not detected despite a condition still being possible. Both are reasons clinicians consider the complete liver panel, symptoms, imaging, and other autoimmune markers 3.

Test or resultWhat it checksHow it may be used
AMAAnti-mitochondrial antibodies in bloodSupports PBC when the liver-test pattern suggests cholestasis 3
AMA-M2A PBC-associated subtype of AMAMay add specificity in an autoimmune liver evaluation 3
Alkaline phosphataseA liver and bile-duct enzymeA persistently high level can prompt cholestasis and PBC evaluation 1
Mitochondrial DNA testingGenetic changes involving mitochondriaUsed for suspected genetic mitochondrial disorders, not AMA-related autoimmune liver evaluation 6

Do you need to fast or prepare for the test?

For an AMA blood draw, fasting is often not required for the antibody test alone. However, follow your ordering laboratory’s instructions because other tests collected at the same visit may have different preparation rules 2.

  • Bring an up-to-date list of prescription medicines, nonprescription medicines, vitamins, and supplements.
  • Tell the ordering clinician about known liver disease, autoimmune conditions, alcohol use, pregnancy, and recent illnesses.
  • Ask whether any other ordered tests require fasting.
  • Expect a routine blood draw from a vein, commonly in the arm.

The blood draw has the usual small risks of laboratory testing, such as brief soreness, bruising, bleeding, lightheadedness, or rarely infection at the draw site 2.

What other tests may be ordered with a mitochondrial antibody test?

A mitochondrial antibody test is usually one part of a larger liver evaluation. The next tests depend on your symptoms and liver-test pattern 3 5.

  • A liver panel, often including alkaline phosphatase, AST, ALT, bilirubin, and albumin 2.
  • Immunoglobulin testing, including IgM, which may add context in suspected PBC 3.
  • Antinuclear antibody (ANA) and anti-smooth muscle antibody when autoimmune hepatitis or overlap disease is being considered 5.
  • Ultrasound or MRI-based bile-duct imaging when obstruction or another structural cause needs to be assessed 3.
  • Referral to a gastroenterologist or hepatologist, a liver specialist, when results are positive, unclear, or paired with ongoing abnormal liver tests.

How is this different from mitochondrial disease testing?

AMA testing is an autoimmune antibody test, while mitochondrial disease testing investigates possible genetic or metabolic problems involving mitochondria. These are separate clinical questions, even though both use the word “mitochondrial” 6.

A positive AMA does not mean you have mitochondrial dysfunction, low cellular energy, a longevity problem, or an inherited mitochondrial disorder. It points clinicians toward an autoimmune liver evaluation, especially for PBC 1 3.

If you are learning about mitochondria as cell structures rather than antibodies, our article on the mitochondrial matrix covers that different topic.

What should Chia readers know about this topic?

At Chia, this topic is education-only. We do not currently offer mitochondrial antibody testing, AMA-M2 testing, liver imaging, or hepatology diagnosis through our catalog.

If your result is positive, negative, or borderline, review the complete report with the clinician who ordered it. The exact method, titer or units, reference range, liver enzymes, symptoms, and medical history all matter when deciding whether you need more testing or a liver-specialist referral 3 4.

We do not use AMA results to assess longevity, general mitochondrial performance, or eligibility for any Chia treatment. This test is about autoimmune antibodies and liver evaluation.

FAQ

References

  1. 1.National Institute of Diabetes and Digestive and Kidney Diseases. Primary Biliary Cholangitis. NIDDK, 2024.
  2. 2.MedlinePlus. Antimitochondrial Antibody (AMA) Test. U.S. National Library of Medicine, 2024.
  3. 3.Lindor KD, Bowlus CL, Boyer J, Levy C, Mayo M. Primary Biliary Cholangitis: 2021 Practice Guidance Update From the American Association for the Study of Liver Diseases. Hepatology. 2022.
  4. 4.Mayo Clinic Laboratories. Mitochondrial Antibodies (M2), Serum: Test Overview. Mayo Clinic Laboratories, 2026.
  5. 5.European Association for the Study of the Liver. EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis. Journal of Hepatology. 2017.
  6. 6.Parikh S, Goldstein A, Karaa A, et al. Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genetics in Medicine. 2017.
  7. 7.Hirschfield GM, Dyson JK, Alexander GJM, et al. The British Society of Gastroenterology/UK-PBC primary biliary cholangitis treatment and management guidelines. Gut. 2018.
  8. 8.Abe M, Mashiba T, Zeniya M, et al. Autoimmune hepatitis 2019 update: A review of current diagnosis and management. Hepatology Research. 2020.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

Find what fits your body and your goals.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides